Tanya is a senior policy analyst, working on ethical and legal considerations arising from biomedical innovation and personalised healthcare. She contributes to a broad portfolio of PHG interests, spanning the use of digital technologies, AI and genomics in healthcare and research.
Tanya gained an interest in policy development during a six month voluntary placement at the Progress Educational Trust. Since joining the Foundation in 2017, Tanya has developed expertise in a diverse range of topics including person centred healthcare, ethical issues raised by novel technologies such as genome editing, and the use of citizen generated data. She also contributes to PHG’s ongoing work on polygenic scores.
Many of Tanya’s projects are collaborative, involving external organisations and funders. Most recently, she has been leading work – commissioned by THIS Institute – on the use of visual identifiers for people with dementia.
Tanya holds a bachelor’s degree in Philosophy from Durham University, a Graduate Diploma in Law, and an MA in Medical Ethics and Law from King’s College London.
- Adopting a risk tool for stratification and predictive prevention of oesophageal cancer
- Control of patient information in the COVID-19 era
- Implementing polygenic scores for cardiovascular disease into NHS Health Checks
- Polygenic scores and clinical utility
- Visual identifiers in the care of people with dementia
- Citizen generated data and health: predictive prevention of disease
- The GDPR and genomic data
- Black box medicine and transparency
- Person centred healthcare
- My healthy future: Overdiagnosis
- Polygenic scores, risk and cardiovascular disease
- Personalising prevention for breast cancer
- How do we close the diversity gap in genomics?
- Implementing polygenic scores for heart disease
- What does ‘good governance’ look like for genome editing?
- Using signs and symbols to improve the care of people with dementia
- Genome editing: a broad perspective on a precision technology
- Genome edited babies: An unexpected reality
- Heritable genome editing: navigating the red line
- Healthy ageing: living well, not just living longer
- Too much information – should we sequence babies?
- Should we presume consent for organs?
- Hype versus reality in human embryo genome editing
- Ethical challenges for Generation Genome
- A Principle-Based Approach to Visual Identification Systems for Hospitalized People with Dementia. Brigden, T.V., Mitchell, C., Kuberska, K. Hall, A.. A Principle-Based Approach to Visual Identification Systems for Hospitalized People with Dementia. Bioethical Inquiry (2023). https://doi.org/10.1007/s11673-023-10315-x
- Ethical and legal implications of implementing risk algorithms for early detection and screening for oesophageal cancer, now and in the future. Tanya Brigden, Colin Mitchell, Elizabeth Redrup Hill and Alison Hall. PLOS ONE. 2023 October. https://doi.org/10.1371/journal.pone.0293576
- Ethical and legal considerations influencing human involvement in the implementation of artificial intelligence in a clinical pathway: A multi-stakeholder perspective.
Elizabeth Redrup Hill, Colin Mitchell, Tanya Brigden and Alison Hall. Frontiers in Digital Health. 2023 March. https://doi.org/10.3389/fdgth.2023.1139210 - How can we address the uncertainties regarding the potential clinical utility of polygenic score-based tests?
Moorthie S, Hall A, Babb de Villiers C, Janus J, Brigden T, Blackburn L, Kroese M. Future Medicine. 15 March 2022.
